Exploration and optimisation of structure-activity relationships of new triazole-based C-terminal Hsp90 inhibitors towards in vivo anticancer potency.
Dernovšek J, Zajec Ž, Poje G, Urbančič D, Sturtzel C, Goričan T, Grissenberger S, Ciura K, Woziński M, Gedgaudas M, Zubrienė A, Grdadolnik SG, Mlinarič-Raščan I, Rajić Z, Cotman AE, Zidar N, Distel M, Tomašič T.
Dernovšek J, et al. Among authors: rajic z.
Biomed Pharmacother. 2024 Aug;177:116941. doi: 10.1016/j.biopha.2024.116941. Epub 2024 Jun 17.
Biomed Pharmacother. 2024.
PMID: 38889640
Free article.